Cafepharma Today

October 15 2024 - J&J reports Q3 sales surge of 5.2% despite EPS decline due to M&A activity
J&J reports Q3 sales surge of 5.2% despite EPS decline due to M&A activity
AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential
Genentech’s Evrysdi helped babies with SMA reach rare milestones in Phase II trial
Walgreens loses another $3 billion and plans to close 1,200 stores
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec, Canada
Saturday, August 23, 2008 - 10:39am
tags:
FDA wants clear drug labels
Allentown Morning Call, PA
Saturday, August 23, 2008 - 10:37am
tags:
Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:
Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
Indevus Pharmaceuticals Announces Completion Of Enrollment In Phase III Trial Of PRO 2000
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
FDA Needs Nine More Months to Study Vytorin, Cancer Link
MedHeadlines
Saturday, August 23, 2008 - 10:30am
tags:
Health Winners & Losers: Alpharma
Yahoo/TheStreet.com
Friday, August 22, 2008 - 7:23pm
tags:
BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 7:22pm
tags:
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Friday, August 22, 2008 - 7:21pm
tags:
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Friday, August 22, 2008 - 7:20pm
tags:
King Pharma raises pressure on rival
Financial Times
Friday, August 22, 2008 - 7:19pm
tags:
Abbott Tries a Crash Diet
Motley Fool
Friday, August 22, 2008 - 4:27pm
tags:
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Friday, August 22, 2008 - 3:18pm
tags:
Alpharma shares surge on King buyout offer
Forbes
Friday, August 22, 2008 - 3:17pm
tags:
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
WSJ Online
Friday, August 22, 2008 - 10:02am
tags:
Merger Watch: APP Pharmaceuticals - Fresenius
Seeking Alpha
Friday, August 22, 2008 - 10:01am
tags:
Onyx and Bayer say patients are enrolling in trial of Nexavar for liver cancer
Yahoo/AP
Friday, August 22, 2008 - 9:39am
tags:
Eli Lilly's Cymbalta gets expanded European approval as anxiety disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 9:36am
tags:
Fresenius Stays Strong in Tough Times
Businessweek
Friday, August 22, 2008 - 9:34am
tags:
FDA: Vytorin Not Linked to Cancer Risk
WSJ Online
Friday, August 22, 2008 - 9:33am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

If Plan Sponsors Are So Unhappy with Their PBMs’ Transparency, Why Won’t They Change the Model?
Drug Channels
Half-Full and Half-Empty AI Glasses
In the Pipeline
As MFP Approaches, Transparency Is More Important Than Ever
Drug Channels
Long, Slow Stories
In the Pipeline
Coronavirus Vaccination: Room for Improvement
In the Pipeline
Five Crucial Trends Facing U.S. Drug Wholesalers in 2024 and Beyond
Drug Channels
The 2024 Chemistry Nobel: Computational Protein Design
In the Pipeline
Cryo-EM to the Rescue
In the Pipeline
NOW AVAILABLE: 2024–25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
Drug Channels

Latest Jobs

Virtual Lead Generation & Sales Specialist - Pharmaceuticals
Jacksonville, Florida, 32290
Syneos Health/ inVentiv Health Commercial LLC
Neuroscience Account Manager (Psychiatry) - Pensacola, FL
Pensacola, Florida, 32573
Vanda Pharmaceuticals
Structural Heart/ICE Territory Sales Manager, Northwest
Issaquah, Washington, 98027
Siemens Medical Solutions USA, Inc
Sales Executive
Everett, Washington, 98213
Abel Consulting
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia,
Otsuka
Territory Account Manager
Orange, California, 92613
Syneos Health/ inVentiv Health Commercial LLC
Pharmaceutical Sales Customer Engagement, CNS - Charlottesville, VA
Roanoke, Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement - Chicago W, IL
Chicago, Illinois,
Otsuka
Pharmaceutical Sales Customer Engagement- Corpus Christi, TX
Corpus Christi, Texas,
Otsuka
Hearing Aid Sales Consultant
Barrington, Rhode Island, 02806
Beltone New England
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information